✦ LIBER ✦

Impact of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod: Subgroup analyses of the Fingolimod Research Evaluating Effects of Daily Oral Therapy in Multiple Sclerosis (FREEDOMS) study

✍ Scribed by Kremenchutzky, Marcelo; O’Connor, Paul; Hohlfeld, Reinhard; Zhang-Auberson, Lixin; von Rosenstiel, Philipp; Meng, Xiangyi; Grinspan, Augusto; Hashmonay, Ron; Kappos, Ludwig

Book ID: 121821912
Publisher: Elsevier
Year: 2014
Tongue: English
Weight: 538 KB
Volume: 3
Category: Article
ISSN: 2211-0348
DOI: 10.1016/j.msard.2013.10.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of prior treatment status and rea

Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing–Remitting Multiple Sclerosis (TRANSFORMS)

✍ Khatri, B.O.; Pelletier, J.; Kappos, L.; Hartung, H.-P.; Comi, G.; Barkhof, F.; 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 600 KB